Steroid hormone rapid signaling: The pivotal role of S-Palmitoylation

IUBMB Life

Volumn 58, Issue 12, 2006, Pages 716-719

  Marino, Maria ^a   Ascenzi, Paolo ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

Plasma membrane localization; Rapid non genomic signaling; S palmitoylation; Steroid hormone receptors

Indexed keywords

ESTROGEN RECEPTOR ALPHA; STEROID RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE; CONSENSUS SEQUENCE; HUMAN; NUCLEOTIDE SEQUENCE; PALMITOYLATION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CELL MEMBRANE; ESTROGEN RECEPTOR ALPHA; GONADAL STEROID HORMONES; HUMANS; MOLECULAR SEQUENCE DATA; PALMITIC ACID; PHYLOGENY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 34250213666     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540601019485     Document Type: Article

References (36)

1. Gronemeyer, H., Gustafsson, J.-Å., and Laudet, V. (2004) Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3, 950-964.
2. Laudet, V., Auwerx, J., Gustafsson, J.-Å., and Wahli, W. (1999) A unified nomenclature system for the nuclear receptor superfamily. Cell 97, 161-163.
3. Escriva, H., Bertrand, S., and Laudet, V. (2004) The evolution of the nuclear receptor superfamily. In: Essay in Biochemistry: The Nuclear Receptor Superfamily (McEwan, I. J., ed.), pp. 11-26, Portland Press, London.
4. Ascenzi, P., Bocedi, A., and Marino, M. (2006) Structure-function relationship of estrogen receptor α and β: impact on human health. Mol. Aspects Med. 27, 299-402.
5. Baker, M. E. (2004) Co-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors. Mol. Cell. Endocrinol. 215, 55-62.
6. Jensen, E. V. (2005) The contribution of 'alternative approaches' to understanding steroid hormone action. Mol. Endocrinol. 19, 1439-1442.
7. O'Malley, B. W. (2005) A life-long search for the molecular pathways of steroid hormone action. Mol. Endocrinol. 19, 1402-1411.
8. Losel, R. M., Falkenstein, E., Feuring, M., Schultz, A., Tillmann, H. C., Rossol-Haseroth, K., and Wehling, M. (2003) Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83, 965-1016.
9. Norman, A. W., Mizwicki, M. T., and Norman, D. P. (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat. Rev. Drug Discov. 3, 27-41.
10. Acconcia, F., Ascenzi, P., Bocedi, A., Spisni, E., Tomasi, V., Trentalance, A., Visca, P., and Marino, M. (2005) Palmitoylation-dependent estrogen receptor a membrane localization: regulation by 17β-estradiol. Mol. Biol. Cell 16, 231-237.
11. Watson, C. S., and Gametchu, B. (2003) Proteins of multiple classes may participate in nongenomic steroid actions. Exp. Biol. Med. (Maywood) 228, 1272-1281.
12. Pappas, T. C., Gametchu, B., and Watson, C. S. (1995) Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 9, 404-410.
13. Gametchu, B., and Watson, C. S. (2002) Correlation of membrane glucocorticoid receptor levels with glucocorticoid-induced apoptotic competence using mutant leukemic and lymphoma cells lines. J. Cell. Biochem. 87, 133-146.
14. Bartholome, B., Spies, C. M., Gaber, T., Schuchmann, S., Berki, T., Kunkel, D., Bienert, M., Radbruch, A., Burmester, G. R., Lauster, R., Scheffold, A., and Buttgereit, F. (2004) Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J. 18, 70-80.
15. Younglai, E. V., Wu, Y., Foster, W. G., Lobb, D. K., and Price, T. M. (2006) Binding of progesterone to cell surfaces of human granulosalutein cells. J. Steroid Biochem. Mol. Biol. 101, 61-67.
16. Brann, D. W., Hendry, L. B., and Mahesh, V. B. (1995) Emerging diversities in the mechanism of action of steroid hormones. J. Steroid Biochem. Mol. Biol. 52, 113-133.
17. Wehling, M. (1997) Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59, 365-393.
18. Grazzini, E., Guillon, G., Mouillac, B., and Zingg, H. H. (1998) Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392, 509-512.
19. Nadal, A., Rovira, J. M., Laribi, O., Leon-Quinto, T., Andreu, E., Ripoll, C., and Soria, B. (1998) Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J. 12, 1341-1348.
20. Nemère, I., and Farach-Carson, M. C. (1998) Membrane receptors for steroid hormones: a case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochem. Biophys. Res. Commun. 248, 443-449.
21. 2+-fluxes in sperm. Endocrinology 140, 5999-6002.
22. Toran-Allerand, C. D., Guan, X., MacLusky, N. J., Horvath, T. L., Diano, S., Singh, M., Connolly, E. S. Jr., Nethrapalli, I. S., and Tinnikov, A. A. (2002) ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22, 8391-8401.
23. Zhu, Y., Bond, J., and Thomas, P. (2003) Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc. Natl. Acad. Sci. USA 100, 2237-2242.
24. Thomas, P., Pang, Y., Filardo, E. J., and Dong, J. (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146, 624-632.
25. Acconcia, F., Bocedi, A., Ascenzi, P., and Marino, M. (2003) Does palmitoylation target estrogen receptors to plasma membrane caveolae? IUBMB Life 55, 33-35.
26. Acconcia, F., Ascenzi, P., Fabozzi, G., Visca, P., and Marino, M. (2004) S-Palmitoylation modulates human estrogen receptor-α functions. Biochem. Biophys. Res. Commun. 316, 878-883.
27. Pietras, R. J., Márquez, D. C., Chen, H.-W., Tsai, E., Weinberg, O., and Fishbein, M. (2005) Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 70, 372-381.
28. Zhou, F., Xue, Y., Yao, X., and Xu, Y. (2006) CSS-Palm: palmitoylation site prediction with a clustering and scoring strategy (CSS). Bioinformatics 22, 894-896.
29. Marino, M., Ficca, R., Ascenzi, P., and Trentalance, A. (2001) Nitric oxide inhibits selectively the 17β-estradiol-induced gene expression without affecting nongenomic events in HeLa cells. Biochem. Biophys. Res. Commun. 286, 529-533.
30. Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., and Shine, J. (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231, 1150-1154.
31. Bijlmakers, M. J., and Marsh, M. (2003) The on-off story of protein palmitoylation. Trends Cell Biol. 13, 32-42.
32. Smotrys, J. E., and Linder, M. E. (2004) Palmitoylation of intracellular signaling proteins: regulation and function. Annu. Rev. Biochem. 73, 559-587.
33. Dunphy, J. T., and Linder, M. E. (1998) Signalling functions of protein palmitoylation. Biochim. Biophys. Acta. 1436, 245-261.
34. Robinson, L. J., Busconi, L., and Michel, T. (1995) Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J. Biol. Chem. 270, 995-998.
35. Marino, M., Ascenzi, P., and Acconcia, F. (2006) S-palmitoylation modulates estrogen receptor α localization and functions. Steroids 71, 298-303.
36. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) CLUSTAL W. Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680.